Neuroblastoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma
Conditions:   Refractory Neuroblastoma;   Relapsed Neuroblastoma;   High-risk Neuroblastoma Intervention:   Biological: GPC2 CAR T cells Sponsors:   Stephan Grupp MD PhD;   Children's Hospital of Philadelphia;   Tmunity Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2022 Category: Research Source Type: clinical trials